NCT06120075
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06120075
Title A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies (ARC-27)
Acronym ARC-27
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Arcus Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Georgetown Washington D.C. District of Columbia 20007 United States Details
Emory University Atlanta Georgia 30322 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Icahn School of Medicine at Mount Sinai/ The Tisch Cancer Center New York New York 10128 United States Details
University Of Pennsylvania, Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Mary Crowley Dallas Texas 75230 United States Details
START - South Texas Accelerated Research Therapeutics, LLC. San Antonio Texas 78229 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
Next Oncology Virginia Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field